1. Home
  2. FSBW vs ENGN Comparison

FSBW vs ENGN Comparison

Compare FSBW & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FSBW
  • ENGN
  • Stock Information
  • Founded
  • FSBW 1936
  • ENGN 1999
  • Country
  • FSBW United States
  • ENGN Canada
  • Employees
  • FSBW N/A
  • ENGN N/A
  • Industry
  • FSBW Banks
  • ENGN
  • Sector
  • FSBW Finance
  • ENGN
  • Exchange
  • FSBW Nasdaq
  • ENGN Nasdaq
  • Market Cap
  • FSBW 318.4M
  • ENGN 297.7M
  • IPO Year
  • FSBW 2012
  • ENGN N/A
  • Fundamental
  • Price
  • FSBW $36.76
  • ENGN $5.40
  • Analyst Decision
  • FSBW Hold
  • ENGN Buy
  • Analyst Count
  • FSBW 1
  • ENGN 9
  • Target Price
  • FSBW $44.00
  • ENGN $25.22
  • AVG Volume (30 Days)
  • FSBW 12.6K
  • ENGN 52.3K
  • Earning Date
  • FSBW 04-23-2025
  • ENGN 03-10-2025
  • Dividend Yield
  • FSBW 2.94%
  • ENGN N/A
  • EPS Growth
  • FSBW N/A
  • ENGN N/A
  • EPS
  • FSBW 4.36
  • ENGN N/A
  • Revenue
  • FSBW $139,150,000.00
  • ENGN N/A
  • Revenue This Year
  • FSBW $9.22
  • ENGN N/A
  • Revenue Next Year
  • FSBW $6.31
  • ENGN N/A
  • P/E Ratio
  • FSBW $8.43
  • ENGN N/A
  • Revenue Growth
  • FSBW 0.09
  • ENGN N/A
  • 52 Week Low
  • FSBW $30.64
  • ENGN $4.42
  • 52 Week High
  • FSBW $49.15
  • ENGN $18.40
  • Technical
  • Relative Strength Index (RSI)
  • FSBW 39.72
  • ENGN 39.68
  • Support Level
  • FSBW $35.46
  • ENGN $4.85
  • Resistance Level
  • FSBW $38.01
  • ENGN $5.55
  • Average True Range (ATR)
  • FSBW 0.94
  • ENGN 0.56
  • MACD
  • FSBW -0.12
  • ENGN -0.00
  • Stochastic Oscillator
  • FSBW 30.66
  • ENGN 43.06

About FSBW FS Bancorp Inc.

FS Bancorp Inc is the holding company of 1st Security Bank, a diversified lender with a focus on the origination of commercial real estate, one-to-four-family, and home equity loans, consumer loans, including a variety of indirect home improvement (fixture secured loans), and marine loans, and commercial business loans. The company has two operating segments; The commercial and consumer banking segment provides diversified financial products and services to its commercial and consumer customers through Bank branches, automated teller machines, online banking platforms, mobile banking apps, and telephone banking, and The home lending segment originates one-to-four-family residential mortgage loans for sale in the secondary markets as well as loans held for investment.

About ENGN enGene Holdings Inc.

enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

Share on Social Networks: